SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Transgene Biotek informs about confirmation certificate

06 Jan 2022 Evaluate

Transgene Biotek has informed that it enclosed confirmation certificate dated 03rd January 2022 pursuant to Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 provided by Registrar and Share Transfer Agent ‘Bigshare Services', regarding details of shares of the Company dematerialized / rematerialized through NSDL & CDSL from 01.10.2021 to 31.12.2021.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

3.10 0.22 (7.64%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 435.70
Indegene 486.80
CMS Info Systems 318.00
JITF Infralogistics 338.00
Sagility 42.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×